Showing results (361-370 of 419) with videos related to
Sort By:
Pageof 42
Journal for Immunotherapy of Cancer|December 4, 2025
rs10204525 binding to miR-4717-3p modulates PD-1 expression and predicts the development of immune-related adverse events in patients with advanced cancer treated with anti-PD-1/PD-L1 therapyGiovanna Polcaro, Luigi Liguori, Valentina Manzo, et al.Journal of Translational Medicine|December 5, 2024
High tumor mutational burden assessed through next-generation sequencing predicts favorable survival in microsatellite stable metastatic colon cancer patientsAnnabella Di Mauro, Mariachiara Santorsola, Giovanni Savarese, et al.Frontiers in Immunology|March 16, 2019
Iron and Ferritin Modulate MHC Class I Expression and NK Cell RecognitionRosa Sottile, Giorgia Federico, Cinzia Garofalo, et al.Oncology and Therapy|June 28, 2024
Exploring a Novel Approach to Spare Classic Chemotherapy in HER2-Low, ER-Positive Breast Cancer Based on Trastuzumab Deruxtecan Combined with Endocrine TherapyLuca Scafuri, Carlo Buonerba, Vincenzo Di Lauro, et al.Neoplasia (New York, N.Y.)|February 25, 2014
HLA class II antigen expression in colorectal carcinoma tumors as a favorable prognostic markerGiuseppe Sconocchia, Serenella Eppenberger-Castori, Inti Zlobec, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinomaLiz Y Han, Mavis S Fletcher, Diana L Urbauer, et al.Journal of Personalized Medicine|February 25, 2023
Long COVID: Clinical Framing, Biomarkers, and Therapeutic ApproachesValeria Conti, Graziamaria Corbi, Francesco Sabbatino, et al.Cancers|June 2, 2021
The Ratio of GrzB+ - FoxP3+ over CD3+ T Cells as a Potential Predictor of Response to Nivolumab in Patients with Metastatic MelanomaGiosuè Scognamiglio, Mariaelena Capone, Francesco Sabbatino, et al.International Journal of Molecular Sciences|September 23, 2022
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GISTErika Fiorino, Alessandra Merlini, Lorenzo D'Ambrosio, et al.Frontiers in Medicine|February 9, 2023
Hypertension, type 2 diabetes, obesity, and p53 mutations negatively correlate with metastatic colorectal cancer patients' survivalAlessandro Ottaiano, Mariachiara Santorsola, Luisa Circelli, et al.Pageof 42